90 cancer groups and centers urge CMS to rescind proposed lung cancer screening reimbursement cuts

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

90 CANCER GROUPS AND CANCER CENTERS, in a sign-on letter, urged the Center for Medicare & Medicaid Services to rescind proposed reimbursement cuts for lung cancer screening in its proposed rule on the 2017 Hospital Outpatient Prospective Payment System. The proposal lowers the reimbursement for low-dose CT lung cancer screenings by 44 percent, from $112.49...

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe

YOU MAY BE INTERESTED IN

The day before health economist Jay Bhattacharya stepped into his new role as NIH director, he sent a document to his employees outlining his top five priorities for the department, which included “reproducibility” and “transparency,” two themes he discussed at his confirmation hearings (The Cancer Letter, March 7, 2025).

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login